blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3230309

EP3230309 - METHODS OF PRODUCING LONG ACTING CTP-MODIFIED GROWTH HORMONE POLYPEPTIDES [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  02.02.2024
Database last updated on 27.07.2024
FormerThe patent has been granted
Status updated on  24.02.2023
FormerGrant of patent is intended
Status updated on  05.10.2022
FormerExamination is in progress
Status updated on  27.04.2018
FormerRequest for examination was made
Status updated on  15.09.2017
FormerThe international publication has been made
Status updated on  05.07.2017
Most recent event   Tooltip02.02.2024Lapse of the patent in a contracting state
New state(s): CZ, DK		published on 06.03.2024  [2024/10]
02.02.2024No opposition filed within time limitpublished on 06.03.2024  [2024/10]
Applicant(s)For all designated states
OPKO Biologics Ltd.
16 Ashlegan Street
Kiryat Gat, 8211804 / IL
[2017/42]
Inventor(s)01 / HERSHKOVITZ, Oren
Kibbutz Revadim
P.O.B. 215
7982000 M.P. Shikmim / IL
02 / MOSCHCOVICH, Laura
Sireni 6
5401844 Givat Shmuel / IL
 [2017/42]
Representative(s)Maschio & Soames IP Ltd
30 Carlton Crescent
Southampton SO15 2EW / GB
[2023/13]
Former [2017/42]Pearl Cohen Zedek Latzer Baratz UK LLP
16 Upper Woburn Place
London WC1H 0BS / GB
Application number, filing date15828386.110.12.2015
[2017/42]
WO2015IL51196
Priority number, dateUS201462090104P10.12.2014         Original published format: US 201462090104 P
US201462090116P10.12.2014         Original published format: US 201462090116 P
US201462090124P10.12.2014         Original published format: US 201462090124 P
[2017/42]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2016092549
Date:16.06.2016
Language:EN
[2016/24]
Type: A1 Application with search report 
No.:EP3230309
Date:18.10.2017
Language:EN
The application published by WIPO in one of the EPO official languages on 16.06.2016 takes the place of the publication of the European patent application.
[2017/42]
Type: B1 Patent specification 
No.:EP3230309
Date:29.03.2023
Language:EN
[2023/13]
Search report(s)International search report - published on:EP16.06.2016
ClassificationIPC:A61K38/00, C12N9/64, C07K14/61, C07K14/59
[2022/39]
CPC:
C07K14/59 (EP,CN,IL,KR,RU,US); C12N15/85 (CN,IL,RU,US); A61K38/00 (EP,IL,RU,US);
C07K14/61 (EP,CN,IL,KR,RU,US); C07K1/34 (KR); C07K14/505 (IL,RU,US);
C07K14/555 (IL,RU,US); C07K14/575 (IL,RU,US); C12N9/6437 (EP,IL,RU,US);
C12N9/644 (EP,IL,RU,US); C12Y304/21021 (EP,IL,RU,US); C12Y304/21022 (EP,IL,RU,US);
G06Q10/0633 (EP,US); G06Q10/0637 (EP,US); G06Q10/06393 (EP,US);
G06Q30/0201 (EP,US); C07K2319/00 (IL,US); C07K2319/31 (EP,CN,IL,US) (-)
Former IPC [2017/42]C07K14/61, C07K14/59
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2017/42]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
MDNot yet paid
TitleGerman:VERFAHREN ZUR HERSTELLUNG LANGWIRKENDER CTP-MODIFIZIERTER WACHSTUMSHORMONPOLYPEPTIDE[2017/42]
English:METHODS OF PRODUCING LONG ACTING CTP-MODIFIED GROWTH HORMONE POLYPEPTIDES[2017/42]
French:PROCÉDÉS DE PRODUCTION DE POLYPEPTIDES D'HORMONE DE CROISSANCE MODIFIÉS PAR CTP À ACTION PROLONGÉE[2017/42]
Entry into regional phase30.06.2017National basic fee paid 
30.06.2017Designation fee(s) paid 
30.06.2017Examination fee paid 
Examination procedure30.06.2017Amendment by applicant (claims and/or description)
30.06.2017Examination requested  [2017/42]
30.06.2017Date on which the examining division has become responsible
25.04.2018Despatch of a communication from the examining division (Time limit: M06)
31.10.2018Reply to a communication from the examining division
22.02.2019Despatch of a communication from the examining division (Time limit: M06)
11.12.2019Reply to a communication from the examining division
30.03.2020Despatch of a communication from the examining division (Time limit: M06)
30.10.2020Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
07.01.2021Reply to a communication from the examining division
01.06.2022Cancellation of oral proceeding that was planned for 28.06.2022
08.06.2022Despatch of a communication from the examining division (Time limit: M02)
28.06.2022Date of oral proceedings (cancelled)
15.07.2022Reply to a communication from the examining division
06.10.2022Communication of intention to grant the patent
14.02.2023Fee for grant paid
14.02.2023Fee for publishing/printing paid
14.02.2023Receipt of the translation of the claim(s)
Divisional application(s)EP23164376.8  / EP4253407
Opposition(s)03.01.2024No opposition filed within time limit [2024/10]
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
07.01.2021Request for further processing filed
07.01.2021Full payment received (date of receipt of payment)
Request granted
14.01.2021Decision despatched
The application is deemed to be withdrawn due to failure to reply to the examination report
11.12.2019Request for further processing filed
11.12.2019Full payment received (date of receipt of payment)
Request granted
19.12.2019Decision despatched
Fees paidRenewal fee
27.12.2017Renewal fee patent year 03
31.12.2018Renewal fee patent year 04
27.12.2019Renewal fee patent year 05
28.12.2020Renewal fee patent year 06
10.11.2021Renewal fee patent year 07
09.12.2022Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipCZ29.03.2023
DK29.03.2023
EE29.03.2023
FI29.03.2023
LT29.03.2023
LV29.03.2023
RO29.03.2023
RS29.03.2023
SK29.03.2023
SM29.03.2023
GR30.06.2023
PT31.07.2023
[2024/10]
Former [2023/50]EE29.03.2023
FI29.03.2023
LT29.03.2023
LV29.03.2023
RO29.03.2023
RS29.03.2023
SK29.03.2023
SM29.03.2023
GR30.06.2023
PT31.07.2023
Former [2023/49]EE29.03.2023
FI29.03.2023
LT29.03.2023
LV29.03.2023
RO29.03.2023
RS29.03.2023
SM29.03.2023
GR30.06.2023
PT31.07.2023
Former [2023/48]EE29.03.2023
FI29.03.2023
LT29.03.2023
LV29.03.2023
RS29.03.2023
SM29.03.2023
GR30.06.2023
PT31.07.2023
Former [2023/46]FI29.03.2023
LT29.03.2023
LV29.03.2023
RS29.03.2023
SM29.03.2023
GR30.06.2023
PT31.07.2023
Former [2023/37]FI29.03.2023
LT29.03.2023
LV29.03.2023
RS29.03.2023
GR30.06.2023
Former [2023/36]FI29.03.2023
LT29.03.2023
LV29.03.2023
RS29.03.2023
Former [2023/34]LT29.03.2023
RS29.03.2023
Former [2023/33]LT29.03.2023
Cited inInternational search[XY]US2009312254  (FARES FUAD [IL], et al) [X] 21-25 * example 7;; sequence 39 * [Y] 1-20;
 [XY]WO2014080401  (PROLOR BIOTECH INC [IL]) [X] 21-25 * examples of the application; paragraphs [0313] , [ 317]; table 2 * [Y] 1-20;
 [Y]  - ANNAMARIE C. DALTON ET AL, "Over-expression of secreted proteins from mammalian cell lines", PROTEIN SCIENCE, US, (20140311), vol. 23, no. 5, doi:10.1002/pro.2439, ISSN 0961-8368, pages 517 - 525, XP055258467 [Y] 1-20 * the whole document * * figure 1 *

DOI:   http://dx.doi.org/10.1002/pro.2439
by applicantEP0167825
 EP0264166
 US4873316
 WO8910756
 US5122458
 US5464764
 US5487992
 WO9715664
 US5712122
    - GELLERFORS ET AL., J PHARM BIOMED ANAL, (1989), vol. 7, pages 173 - 183
    - BITTER ET AL., METHODS IN NZYMOL., (1987), vol. 153, pages 516 - 544
    - STUDIER ET AL., METHODS IN ENZYMOL., (1990), vol. 185, pages 60 - 89
    - BRISSON ET AL., NATURE, (1984), vol. 310, pages 511 - 514
    - TAKAMATSU ET AL., EMBO J., (1987), vol. 6, pages 307 - 311
    - CORUZZI ET AL., EMBO J., (1984), vol. 3, pages 1671 - 1680
    - BROGLI ET AL., SCIENCE, (1984), vol. 224, pages 838 - 843
    - GURLEY ET AL., MOL. CELL, (1986), vol. 6, pages 559 - 565
    - WEISSBACH; WEISSBACH, Methods for Plant Molecular Biology, ACADEMIC PRESS, (1988), pages 421 - 463
    - PINKERT ET AL., GENES DEV., (1987), vol. 1, pages 268 - 277
    - CALAME ET AL., ADV. IMMUNOL., (1988), vol. 43, pages 235 - 275
    - WINOTO ET AL., EMBO J., (1989), vol. 8, pages 729 - 733
    - BANERJI ET AL., CELL, (1983), pages 33729 - 740
    - BYRNE ET AL., PROC. NATL. ACAD. SCI. USA, (1989), vol. 86, pages 5473 - 5477
    - EDLUNCH ET AL., SCIENCE, (1985), vol. 230, pages 912 - 916
    - SROUR, M.A. ET AL., THROMB. HAEMOST., (2003), vol. 90, pages 398 - 405
    - GILBOA, BIOTECHNIQUES, (1986), vol. 4, no. 6, pages 504 - 512
    - Current Protocols in Cytometry, JOHN WILEY & SONS; INC.
    - "Genetic Engineering of Animals Cells", WIRTH; HAUSER, Biotechnology, VCH, vol. 2, pages 663 - 744
    - Methods of Enzymology, ACADEMIC PRESS, INC
    - GOSSEN, M. ET AL., CURR OPI BIOTECH, (1994), vol. 5, pages 516 - 520
    - BOOTH ET AL., IMMUNOI. LETT., (1988), vol. 19, pages 65 - 70
    - GARDELLA ET AL., J. BIOL. CHEM., (1990), vol. 265, pages 15854 - 15859
    - RAMSEY ET AL., IN VITRO, (1984), vol. 20, page 802
    - Remington's Pharmaceutical Sciences, MACK PUBLISHING CO.
    - LANGER, SCIENCE, (1990), vol. 249, pages 1527 - 1533
    - TREAT ET AL., Liposomes in the Therapy of Infectious Disease and Cancer, LISS, (1989), pages 353 - 365
    - LIPOSOMES IN THE THERAPY OF INFECTIOUS DISEASE AND CANCER, pages 317 - 327
    - SEFTON, CRC CRIT. REF. BIOMED. ENG., (1987), vol. 14, page 201
    - BUCHWALD ET AL., SURGERY, (1980), vol. 88, page 507
    - SAUDEK ET AL., N. ENGL. J. MED., (1989), vol. 321, page 574
    - GOODSON, MEDICAL ' APPLICATIONS OF CONTROLLED RELEASE, (1984), vol. 2, pages 115 - 138
    - FINGL ET AL., The Pharmacological Basis of Therapeutics, (1975), page I
    - SPEISER, PHARM. RES., (1991), vol. 8, pages 47 - 54
    - J. E. DIEDERICHS, PHARM./ND, (1994), vol. 56, pages 267 - 275
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.